Publications by authors named "Martin Janousek"

Claim this Profile
M
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.
Lihua E Budde, Huilai Zhang, Won-Seog Kim, Dai Maruyama, Eduardo M Rego, Martin Janousek

J Clin Oncolยท December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis